"Sikuwahi ambiwa jinsi nilivyokuwa mgonjwa wala Sikuelewa kwamba, Hepatitis C imenidhuru na uharibifu sana. Nildhani kuwa tatizo langu lilikuwa

Similar documents
Towards. New HIV Infections Among Children in Tanzania

CHAMA CHA USHIRIKA WA AKIBA NA MIKOPO TANESCO

OKOA FIGO LAKO. Dr Gabriel L. Upunda Dar es Salaam, Tanzania. Free access to read, download and print. Interna

ANDIKO LA MAELEZO YA KIAFYAJAMII KUSIMAMISHA OVADOSI USAMBAZAJI WA NALOXONE BAINA YA WENZI

KISUKARI ENGLISH/SWAHILI

Kenya W1 Smokeless Survey Code: KE1-L Languages: Kiswahili Mode: Face to Face

OCV SEB Study: Explanatory Model Interview Catalogue (EMIC) Survey Phase: 2, Study Level: IV

ALBINO. kinyume na MTU MWENYE ALBINISM (PWA) MSIMAMO RASMI WA UNDER THE SAME SUN (UTSS)

WADAU: Kodi inaongeza bei kondomu

Kuendesha Gari ukiwa na Ugonjwa wa Kisukari

NANDI COUNTY ASSEMBLY OFFICIAL REPORT

THE Geita Gold Mine. By 2007, about 2 million. GGM extends financial support for institutions fighting HIV/AIDS. Our Vision:

Acrobat 69% WG READ THE LABEL BEFORE USING (SOMA KIBANDIKO CHA MAELEZO KABLA YA KUTUMIA) KEEP LOCKED OUT OF REACH OF CHILDREN (WEKA MBALI NA WATOTO)

GAIRO HABARI MOTO MOTO

HIV and AIDS Education Urged for Fishing Areas. Our Vision:

GRIZLY. 1 Liter INSECTICIDE. A systemic and contact insecticide for the control of aphids, whiteflies and thrips on roses and tomatoes.

NACOPHA yaanika fursa

ATD Fourth World Registration nº under NGO Act, 2002 P.O. Box 61786, Dar es Salaam Tanzania Phone number:

INAUGURALDISSERTATION

COME FIRST, GET RIGHT ANSWER

Hospice and Palliative Care. Team Building: Involving the Church

AN EVALUATION OF INTEGRATED INTERVENTIONS TO IMPROVE ACCESS TO MALARIA TREATMENT IN TANZANIA (ACCESS PROGRAMME)

Understanding and improving malaria diagnosis in health facilities in Dar es Salaam, Tanzania

AZIMUT 320 SC. 1 Liter FUNGICIDE. An agricultural systemic and translaminar fungicide for the control of yellow rust and stem rust in wheat

Promotion of Community based cultivation of Hibiscus sabdariffa, Moringa oleifera, Adansonia digitata and Aloe vera

TAARIFA YA UFUATILIAJI NA TATHMINI YA UKIMWI MKOA WA MBEYA

ADEQUACY OF AXILLARY LYMPH NODE DISSECTION IN THE MANAGEMENT OF BREAST CANCER AT KENYATTA NATIONAL HOSPITAL

ACCESS TO ART, ADHERENCE AND DRUG RESISTANCE AMONG HIV-POSITIVE PATIENTS IN RURAL TANZANIA

Meltatox 385 EC. Emulsifiable Concentrate FUNGICIDE (KIUAKUVU) KEEP LOCKED OUT OF REACH OF CHILDREN WEKA MBALI NA WATOTO

March 23, 2016 PARLIAMENTARY DEBATES 1 NATIONAL ASSEMBLY OFFICIAL REPORT. Wednesday, 23 rd March, The House met at 9.30 a.m.

PREVALENCE OF KERATOCONJUNCTIVITIS SICCA IN PATIENTS WITH HIV/AIDS ATTENDING THE COUPLES COUNSELLING CENTRE IN KENYATTA NATIONAL HOSPITAL

von Nahya Salim Masoud Aus Zanzibar, United Republic of Tanzania Basel, 2015

Regent 50 SC SUSPENSION CONCENTRATE INSECTICIDE (KIUADUDU)

Embe Halijamenywa: The unpeeled mango

von Amani Shao Aus Kilimanjaro, Tanzania Basel, 2015 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.

Tanzanian team. Editor s Note Tanzania is now witness to unprecedented. Big up to Tanzania s anti-stigma law! Issue No. 011 April. 8- April.

TB/HIV KAP SURVEY REPORT

Assisting Birth Attendants in Providing Acceptable Care under Unacceptable Clinical Realities

Concept Testing Discussion Guide. Tuko Wangapi Tulizana Phase 2 Bagamoyo, November 7, 12. Location..Gender No of participants

English - Swahili Dictionary of Meteorological Terms. Kamusi ya Kiingereza - Kiswahili ya Istilahi za Hali ya Hewa. Kenya Meteorological Department

ENGLISH/SWAHILI BASICS NO SMOKING/USIVUTE SIGARA UNSURE/SINA UHAKIKA

OUTCOMES OF URETHRAL STRICTURE AT MUHIMBILI NATIONAL HOSPITAL AND TUMAINI HOSPITAL, DAR ES SALAAM.

CLIENTS SATISFACTION WITH SERVICES FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV IN DODOMA RURAL DISTRICT

Camilla Wirseen Patna 1 dec Saving Lives

Language Use in the Portrayal of both Women and Men in HIV/AIDS Public Sensitization Texts in the Tanzanian Mass Media


GAINING ACCESS TO PROMPT AND APPROPRIATE MALARIA TREATMENT IN THE KILOMBERO VALLEY, TANZANIA: A HEALTH SOCIAL SCIENCE PERSPECTIVE

The epidemiology of HIV in Canada

Management of Sexually Transmitted and Reproductive Tract Infections

Current Status of Hepatitis C in Canada

Health Canada Endorsed Important Safety Information on Infanrix Hexa

The HIV testing process

Government of Canada Federal AIDS Initiative Milestones

Habari Gani. Save thedate! June 8th. September 2017

HIV, Co-infection & Aging: New Challenges for Gerontology

Respiratory Virus Detections in Canada Respiratory Virus Report, Week 10 - ending March 9, 2019

Poison Control Centres

West Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition

17/18. Annual Report. Canada s voice for treatment access. Listening to and led by people with HIV and HCV

Saskatchewan HIV Strategy: Social Network Approach

The epidemiology of hepatitis C in Canada

BTS NEWSLETTER.

Wazazi Nipendeni (Love me, parents!) Impact of an Integra5on Na5onal Safe Motherhood Campaign in Tanzania

Hepatitis C - results in real life

CHAPTER 4: Population-level interventions

Technology to support a Community of Practice Promoting Healthy Built Environment Policies

HIV/AIDS Epi Update Public Health Agency of Canada

Ee: JQJIATHAfl THSa* V C. S.,7. KIAIB CKE SO. 122SA8.

Antimicrobial Resistant Organisms (ARO) Surveillance SURVEILLANCE REPORT FOR DATA FROM JANUARY TO DECEMBER

A REVIEW OF MANAGEMENT OF FEMORAL NECK FRACTURES IN KENYATTA NATIONAL HOSPITAL BY DR. DAN F.OJ OCHIEL M.B.CH.B (NAIROBI)

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

Healthy Pathways Forward Progress Report. May

Strengthening efforts to eliminate hepatitis C: An overview of the latest in research and implications for frontline workers

Impaired driving statistics

Comparison of HCV Recurrent Viremia Rates in All-Oral and Interferon-Based Regimens

Estimating the Sequestered Load in Plasmodium falciparum Malaria

HIV and AIDS among Aboriginal peoples in Canada: An Epidemiological Overview

Using a Café to Demystify Recommendations, Engage Audiences, and Address Barriers

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada

William W.L. Wong, PhD School of Pharmacy University of Waterloo. CADTH Symposium April 17, 2018

NATIONAL PREVENTION STRATEGY MEETING:

People Living with HIV/AIDS in Canada: A Determinants of Health Perspective Preliminary Findings of the Population-Specific HIV/AIDS Status Report

AIDS PANDEMIC: THE VOICE OF THE YOUTH IN THE KISWAHILI NOVEL

West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 24, 2016 (Week 38)

HIV/AIDS Epi Update Public Health Agency of Canada

Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD

H1N1 Flu Virus (Human Swine Influenza) Information Resources (last updated May 6th, 2009, 5 pm)

Critical Care Medicine. Critical Care Medicine Profile

Viral Hepatitis. WHO Regional Office for Europe July 2013

Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)

W H A T N A C D O E S

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

Estimates of HIV Prevalence and Incidence in Canada, 2011

Report from the National Diabetes Surveillance System:

BTS NEWSLETTER. Chair s Report How we started, What we do now The way ahead - see page 14. "Request for help as BTS enters a new phase"

GRANT DISBURSEMENT REPORT: Donor: Association for Improvement of Mental Health Programs. Beneficiary: KANGEMI COMMUNITY HEALTH VOLUNTEERS GROUP

TUBERCULOSIS IN CANADA 2010 PRE-RELEASE

MINISTRY OF COMMUNITY DEVELOPMENT GENDER AND CHILDREN WOMEN S INFORMATION CENTRE

OxyContin in the 90 days prior to it being discontinued.

COLLABORATIVE STAGE TRAINING IN CANADA

Transcription:

"Sikuwahi ambiwa jinsi nilivyokuwa mgonjwa wala Sikuelewa kwamba, Hepatitis C imenidhuru na uharibifu sana. Nildhani kuwa tatizo langu lilikuwa ugonjwa wa kisukari au ugonjwa wa damu iliyosababisha hala ngozi yangu. Tafadhali, chukua muda tueleze mambo haya."

Baadhi ya ukweli unao kubalika kimataifas (1, 2) Hepatitis C ni ugonjwa wa ini unaosababishwa na virusi vya hepatitis C (HCV) - virusi vinaosababishwa na mzunguko wa damu. virusi inaweza kusababisha maambukizi, tangia ukali kutoka ugonjwa wa kudumu kwa muda wa wiki chache hadi kwa ugonjwa mbaya ya kuadhiri maisha yote. Hivi sasa hakuna chanjo ya hepatitis C. Njia za kawaida za maambukizi ni kupitia njia za sindano zisizo salama, utumizi wa vifaa vya matibabu zisiszo zibiwa kamili, uhamisho wa damu na vipengele vya damu, ambazo hazijachunguzwa. Kote duniani, takriban watu milioni 71 wana ugonjwa huu sugu wa maambukizi ya hepatitis C. Takriban wa asilimia 25 ya watu walio na virusi, huisha bila matibabu. Watu wengine 75% itaendeleza maambukizi ya muda mrefu ya hepatitis C. Bila matibabu, kwa muda mrefu, watu wanao ugonjwa sugu wa hepatitis, huendeleza kuhofu aisha yao,kati zingine, inaweza kukuza saratani ya ini. Mahali popote kati ya 15-30% ya watu ambao wana ugonjwa elekevu wa hepatitis sugu, itasababisha cirrhosis ndani ya miaka 20. Baada ya 2011, dawa mpya za mdomo na viwango vya kutibu zaidi ya 95% ikawa inapatikana kutibu HCV maambukizi sugu. Dawa hizi zinafungua zama mpya katika usimamizi wa maambukizi ya muda mrefu ya HCV, kwa hiyo kupunguza hatari ya kifo kutokana na saratani ya ini na magonjwa ya ini ya mwisho. Mwaka 2011, idadi ya watu wahamiaji Kuathiri ya asilimia 20.6 inayojumuisha idadi ya Kanada, hivyo mmoja kati ya watu watano walikuwa wahamiaji.

Mwaka 2011, idadi ya watu wahamiaji Ilikuwa asilimia 20.6 ya idadi ya Kanada, hivyo mmoja kati ya watu watano, walikuwa wahamiaji.

Baadhi ya ukweli kuhusu Kanada Kulingana na makadirio ya hepatitis C ya kitaifa ya 2011: ATakriban ya watu 300,000 wanaoishi Kanada, wanaishi na virusi vya hepatitis C sugu (3). Hiyo ni sawa na watu sita au saba kutoka kwa Wakridi 1,000. Inakadiriwa 44% ya watu wanaoishi na hepatitis C ya muda mrefu hawajui maambukizi yao (4). Ukimwi wa hepatitis C ni ugonjwa "kimya" kwa sababu mara nyingi hakuna dalili zinaonekana mpaka ini yako imeharibiwa sana (5). Watu wengi walioambukizwa wanaishi kwa miaka 20 au 30 bila hisia mgonjwa. Ugonjwa wa hepatitis C unaoenea sana kati ya watu waliozaliwa kati ya 1945 na 1975. Watu waliozaliwa katika nchi nje ya Kanada ilijumuisha 35.0% ya kesi zote za kupambana na antibody (6). Zaidi ya siku za nyuma Miaka 40 wengi wa wahamiaji wapya wametoka nchi zilizo na ukuaji mkubwa wa hepatitis C kuliko ile Kanada (7). Wahamiaji wana vifo 2-4 vya juu kutoka saratani ya ini na virusivya hepatitis dhidi ya Kanada aliyezaliwa (8). Wahamiaji, wakimbizi na wageni wa Kanada (9) : Moja ya vikundi muhimu ambavyo vinaathiriwa na HCV. Wahamiaji wa Kanada wanakabiliwa na changamoto za kipekee zinazojumuisha vikwazo vya lugha, unyanyapaa, na kutokuwa na uhakika juu ya jinsi ya kwenda mfumo wa afya, kupoteza mitandao ya kijamii na ukosefu wa afya chanjo ya bima ambacho huchelewesha upatikanaji wa matibabu. Uhamiaji wa nchi mpya pia huathiri uwezo wa kujitegemea na kupata huduma za afya na matibabu. Mapendekezo ya sasa ya uchunguzi wa hepatitis C nchini Kanada ni msingi wa tathmini ya mambo ya hatari. Mapendekezo wamewekwa mbele kwa wahamiaji wa screen na wageni hasa kutokana na nchi za mwisho za hepatitis C lakini mipangilio ya huduma ya msingi haipati huduma hii kwa ujumla.

Kanada Njia za uhamisho wa HCV Kwa kawaida, njia ya ya kupata HCV ni kupitia kufidhi kwa damu iliyoambukizwa. Hii inaweza kutokea kama damu ya mtu ambaye ana hepatitis C inakuja damu yako mwenyewe. Hatari ya maambukizi kwa njia ya kuambukizwa kwa damu nchini Kanada imepunguzwa, lakini sio kuondolewa, kupitia kuanzishwa kwa upimaji wa wote wa wafadhili wa damu mwaka 1992. (12,13,14). Wengi wa maambukizi mapya ya HCV yanatokana na upya tena sindano zilizosababishwa au zisizofaa za sindano na sindano kutumika katika taratibu za matibabu, paramedical na meno. Kanada Viwango vya juu zaidi vya maambukizi mapya ya HCV uripotiwa miongoni mwa watumiaji wa madawa (IDU), hasa kutokana na kushirikiana kwa kutumia dawa za kulevya vifaa.

"Sikujua chochote kuhusu hepatitis C; Nilidhani dawa zilikuwa bei ghali sikujua kuhusu wao."

"Nina ugumu wa Kiingereza, kwa hivyo inambidi mwanangu kunisaidia na kuandamana nami hadi kwa daktari." Matibabu Tangu 2010, maendeleo makubwa yamefanywa katika matibabu ya hepatitis C. sugu mpya inayoitwa kaimu moja kwa moja dawa za kulevya (DAA) ni dawa ambazo zinafanya hatua mbalimbali virusi vya virusi ili kuondokana na mwili. Hizi matibabu mpya ni bora sana na inaweza kufikia viwango vya tiba ya zaidi ya 90%. Katika hali nyingi sasa, hakuna haja ya interferon, ambayo ilikuwa na jukumu la madhara mengi awali inayohusishwa na matibabu ya HCV. Matibabu mapya mchanganyiko huhitaji muda mfupi wa matibabu (kati ya 8 hadi Wiki 24), imepungua madhara na inaonekana kuwa ya ufanisi hakuna suala ni hatua gani ya uharibifu wa ini unao. Kwa uchaguzi wa matibabu, tafadhali angalia: http://hepatitiseducation.med.ubc.ca/patients/treatmentoptions/

Kupata daktari Kupata mtoa-huduma wa afya muhimu ni muhimu sana pia Vigumu kupatikana. Wakanada wengi wana daktari wa familia wanaoendea wakati wowote wanahitaji huduma za matibabu. Daktari wa familia hutoa huduma ya msingi ya afya. Daktari wako wa familia atawapeleka muone mtaalamu wakati inahitajika. Unaweza pia kwenda kumtembeelea daktari wakati wowote ule keney kliniki bila uteuzi maarafu. Unaweza kupata daktari kwa: Kuuliza mtu unayemjua. Kuuliza mtu unayemjua kuwasiliana na shirika la wahamiaji ambalo linaweza kuwa kupatikana kwenye tovuti ya Serikali ya Kanada: http://www.cic.gc.ca/english/newcomers/map/services.asp Kuwasiliana na kituo cha afya cha jamii C huko Quebec katika eneo lako kujifunza wakati daktari inapatikana. Ili kupata kliniki ya jamii http://www.cachc.ca/ourmembers/ Ili kupata mtoa huduma wa HCV karibu na huduma maalum za lugha tafadhaliangalia HCV411.ca au simu CATIE malipo bure: 1-800-263-1638. Usiri umehifadhiwa. Hadithi nyingi kuhusu hilo dawa kuwa ngumu, higofya watu - hivyo nio tu kuishi na hilo na usielewe kinachotokea ndani ya ini na hepatitis C sio tu huathiri ini lakini madhara yake pia yanaweza kuonekana katika mwili wote.

Usiri Kanada, huduma za afya hutolewa kwa siri. Hii ina maana kwamba daktari wako hawezi kujadili habari ya afya yako na mtu mwingine bila kibali chako. Angalia: http://www.cic.gc.ca/english/newcomers/after-health-doctor.asp Kujiandaa kwa daktari Kuwa tayari kwa mashauriano yako ni jukumu la pamoja. Andika maswali yoyote uliyo nayo kabla ya kwenda kwako Uteuzi. Mara kwa mara wakati huwa mchache. Ikiwa una matatizo ya lugha, daktari anaweza kupanga kwa kumtafta mkalimani ukiwa na uwezo au unaweza kuja na rafiki / mshirika wako wa kuaminiwa. Ili kupata orodha ya maswali ambayo unazowezataka kuuliza daktari wako tafadhali, angalia: http://hepatitiseducation.med.ubc.ca/patients/ Daktari wako wa huduma ya msingi anaweza kukutuma kwa mtaalam wa hepatitis C kutathmini ugonjwa wa ini na kuamua iwapo wewe utastahiki matibabu ya umma. Uhamisho husubiri kuona mtaalamu nchini Kanada unaweza kuchukua muda. Mtaalam atajadili tiba ipi ya madawa ipi ni bora kwako kwa ukali wa ugonjwa wa ini, virusi vya virusi na ikiwa haujatambuliwa wakati uliopita au labda umetibika katika siku za nyuma. "Ilichukua muda mrefu kuona mtaalamu. Sikuweza kufanya kitu chochote. Nilisubiri muda mrefu kwa rufaa kwa mtaalamu bila kusikia chochote kuhusu kuwa kwenye orodha ya kusubiri. Ilinibidi kumwomba daktari anirupe tena kwa daktari kwa hepatitis yangu C."

Chanjo ya madawa Mafanikio ya hivi karibuni katika idadi na aina ya dawa inapatikana kutibu HCV, hukupa chaguo zaidi kwa daktari wako wakati wa kuamua juu ya mpango wa matibabu. Hata hivyo, kuna vigezo fulani vya ustahiki na vikwazo vya kulipa ya HCV. kaimu ya madawa. Wewe na daktari wako wanaweza kukabiliwa na maamuzi magumu kuhusu tiba. Katika hili hali, njia mbadala zinaweza kuchukuliwa, ikiwa ni pamoja na upungufu wa tiba. Madawa mapya ya HCV ni ghali sana. Kama vile, chanjo ya madawa kutoka kwa serikali na makampuni ya binafsi yanaweza kuhitaji ugonjwa wako wa ini umeendelea kwa hatua fulani kabla ya kuidhinisha gharama za madawa haya. Hata hivyo, kuna lengo la kuongezeka nchini Kanada kwa kutoa zaidi uenezi mkubwa wa madawa haya. Vigezo vya kustahili matibabu inaweza kuhama ili kukaa vizuri kushikamana na daktari wako. Mwezi Februari 2015, Prince Edward Island ikawa mkoa wa kwanza katika Kanada kwa kutoa uongozi na matibabu mkakati kwa ajili ya wagonjwa hepatitis C. Kama ya 2018, Ontario, Saskatchewan, British Columbia, na Quebec itakuwa kufidia gharama ya dawa kwa ajili ya wote wagonjwa hepatitis C, bila kujali ukali wa ugonjwa huo. "Niliambiwa nilikuwa na hepatitis C nilipofika Montreal. Daktari alisema ikuwa nahitaji matibabu - miaka 5 baadaye nilifika Saskatoon na daktari wa familia yangu alisema napaswa kwenda kumwona mtaalamu. Baada ya kutumwa ili kuona mtaalamu wa hepatitis C timu,nilihisi vizuri. Niliona mabadiliko maswali yangu yalijibiwa. Nilifanya maamuzi yangu kulingana Na uchunguzi na habari.

Kwa habari zaidi tafadali muone: Tovuti ya Msingi wa Kikatili ya Kanada: http://www.liver.ca/liver-disease/types/viral_hepatitis/hepatitis_c. aspx au piga simu bure kwa habari zaidi 1.800.563.5483. Kwa chaguo la matibabu ya HCV: http://hepatitiseducation.ca/patients/treatment-options/ Kumbuka Huenda usihitaji kupatiwa mara moja, lakini wewe na daktari wako anahitaji kuwa na mpango wa huduma yako ya ini. Ikiwa hauna hakika kwa ajili ya matibabu, ni muhimu kwamba uhakikishe kuwa ini yako inadhibitiwa kila miezi 6 hadi 12 kufuata maendeleo ya ugonjwa na kuwa na taarifa. http://hepatitiseducation.med.ubc.ca/patients/english-2/ (Angalia sehemu ya "Kama ninayo" )

Hata baada ya kuponywa Kuondoa upya wa matibabu ya baadaye, inawezekana hivyo unahitaji kuwa macho juu ya afya yako na ini. Ikiwa tiba yako ya HCV ilifanyika kwenye hatua ya juu ya ugonjwa (hatua ya kizunguko) hakikisha ufuatane na daktari wako kwa kutumia sampuli sita za kila mwezi kwa skrini ya saratani ya ini. Unaweza bado kuhitajii msaada hata kama unaponywa kupitia matibabu. Kushikamana na huduma inaweza kukupa afya na kijamii ambazo hujawahi kuwa na kabla.

Marejeleo 1. WHO Hepatitis Fact Sheets Oct 2017, Retrieved from http://www.who.int/mediacentre/factsheets/ fs164/en/ 2. Amal Ahmed Mohamed, Tamer A Elbedewy, Magdy El-Serafy, Naglaa El-Toukhy, Wesam Ahmed, Zaniab Ali El Din, Hepatitis C Virus: A Global View, World J Hepatol. 2015 Nov 18; 7(26): 2676 2680. 3. Fact Sheet: Hepatitis C (HCV), British Columbia Centre for Excellence in HIV/AIDS. Retrieved from http://www.cfenet.ubc.ca/sites/default/files/ uploads/hcv%20fact%20sheet.pdf 4. Fact Sheet: The Epidemiology of Hepatitis C in Kanada. Retrieved from http://www.catie.ca/en/ fact-sheets/epidemiology/epidemiology-hepatitisc-kanada 5. Canadian Liver Foundation 2016: Hepatitis C. Retrieved from http://www.liver.ca/liver-disease/ types/viral_hepatitis/hepatitis_c.aspxa. 6. Ha S, Totten S, Pogany L, Wu J, Gale-Rowe M. Hepatitis C in Kanada and the importance of risk-based screening. Can Comm Dis Rep 2016; 42:57-62. 7. Trubnikow M, Yan P, Archibald C., Estimated prevalence of hepatitis C virus infection in Kanada, 2011. Kanada Communicable Disease Report. 2014 Dec 18; 40(19). Retrieved from: http:// www.phac-aspc.gc.ca/publicat/ccdr-rmtc/14vol40/ dr-rm40-19/surveillance-b-eng.php 8. Hepatitis C s Impact on Canadian migrants and newcomers. Retrieved from http://www.catie.ca/ sites/default/files/ethno-hcv-slides-08242016.pdf 9. Rapid Response Service. Rapid Response: Treatment access barriers and related best practices for newcomers living with HIV and/ or HCV, Toronto, ON: Ontario HIV, Treatment Network; November 2014. Retrieved from http:// www.ohtn.on.ca/rapid-response-90-treatmentbarriers-and-best-practices-for-newcomers-livingwith-hivhcv/ 10. Kanada: Immigration by Source Country (2015): The Canadian Magazine of Immigration April 5, 2016 from Government of Kanada. Retrieved from http://kanadaimmigrants.com/kanadaimmigration-by-source-country-2015/ 11. Canadian Liver Foundation, National Hepatitis C Education Program. Retrieved from http://www. cpha.ca/uploads/portals/idp/19081.pdf 12. The University of British Columbia,Hepatitis Education Kanada. Types of viral hepatitis, hepatitis C. Retrieved from http:// hepatitiseducation.med.ubc.ca/patients/english-2/ 13. Legislative Electronic Publications. Manitoba extends extraordinary assistance to hepatitis c, 2001. Retrieved from http://www.gov.mb.ca/chc/ press/top/2001/01/2001-01-18-01.html 14. Luby S, Only 25% blood banks tested blood and blood product donations for HCV infection: Health Policy Plan 2000;15:217 15. Khan A J, Therapeutic injections using nonsterile needles: Bull World Health Organ 2000;78:956 16. Naveed Zafar Janjua, Zahid Ahmad Butt, Bushra Mahmood, Arshad Altaf; Towards safe injection practices for prevention of hepatitis, C transmission in South Asia: Challenges and Progress. World J Gastroenterol 2016 July 7; 22(25):5837-5852 17. Hepatitis C in Kanada: 2005-2010 Surveillance Report, Centre for Communicable Diseases and Infection Control Infectious Disease Prevention and Control Branch, Public Health Agency of Kanada 18. Medscape Medical News from The Liver Meeting 2015: American Association for the Study of Liver Diseases (AASLD) : A Focus on Hepatitis C: Novel Therapeutic. Retrieved from http://www. medscape.com/viewarticle/860477_7 19. Ampuero J, Romero-Gómez M, Reddy KR, Review article: HCV genotype 3 -The new treatment challenge. Aliment Pharmacol Ther. 2014 Apr; 39(7):686-98.

Shukrani Rasilimali hii iliundwa na CTAC. Haikuwezekana bila thamani michango kutoka kwa watu binafsi walioathirika na hepatitis C na watoa huduma katika Kanada ikiwa ni pamoja na: Halmashauri ya Kikatili ya Kanada, Ushirikiano wa Interagency juu ya UKIMWI na Maendeleo, Faundesheni ya Kikiti cha Kanada na msaada wa Kundi la Kazi la Taifa linalojumuisha. Lesley Gallagher, Vancouver Coastal Health/Saskatchewan Infectious Disease Care Network Geri Hirsch, Capital District Health Authority, Halifax, Nova Scotia Naveed Zafar Janjua, BC Centre for Disease Control Nadia Junaid, Community Health Promoter, Unison Health and Community Services Liza McGuinness and Terri Buller-Taylor, Hepatitis Education Kanada Iliyoundwa na: Rounak Khan Muhammad Mushtaq, Committee of Progressive Pakistani Canadians Janet Hatcher Roberts, Centre for Global Health, University of Ottawa Fozia Tanveer, CATIE Imebadilishwa na: Gordon Shallard-Brown Iliyoundwa na Ilitafsiriwa na: Arrachcee Design Fedha kwa mradi huu ilitolewa na:

2018, CTAC (Canadian Treatment Action Council). All rights reserved. www.ctac.ca /ctac.can @ctac_can /CTACtalks Hauko peke yako.